Organometallic Ligands

<p>RO9021 is a synthetic peptide, which is derived from bacterial lipoproteins, with a mechanism of action that targets and modulates specific inflammatory pathways. This peptide interacts with cell surface receptors, such as Toll-like receptors (TLRs), to inhibit the signaling cascades that lead to the production of pro-inflammatory cytokines. By acting on these crucial pathways, RO9021 effectively reduces inflammation and can modulate immune responses.</p>

<p>Tauro-β-muricholic acid sodium is a bile acid derivative, which is naturally sourced from mammalian bile. It plays a crucial role in the regulation of bile acid metabolism by modulating the activity of nuclear receptors in the liver and intestine. This compound acts by inhibiting farnesoid X receptor (FXR) signaling, a nuclear receptor that regulates bile acid synthesis, lipid metabolism, and glucose homeostasis. By influencing these pathways, Tauro-β-muricholic acid sodium is an important tool for scientists studying liver function, cholesterol metabolism, and intestinal microbiome interactions.</p>

<p>Diprovocim-1 is an immunological adjuvant, which is a synthetic compound designed to enhance the body's immune response to an antigen. This compound is crafted through chemical synthesis, representing a class of molecules that actively engage the immune system's receptors to boost the efficacy of vaccines. Diprovocim-1 functions by stimulating Toll-like receptors on immune cells, thereby enhancing the activation and proliferation of antigen-presenting cells. This mode of action is critical for augmenting the body’s adaptive immune response, leading to a more robust and sustained immunity.</p>

<p>Gamma-secretase modulator 1 is a small-molecule therapeutic agent designed to selectively target the enzymatic activity of gamma-secretase, a protease complex involved in the processing of amyloid precursor protein (APP). This compound is chemically synthesized through rational drug design focused on modulating gamma-secretase to alter the production and aggregation of amyloid-beta peptides without affecting other substrates critical to cellular function.</p>

<p>Caspase-3/7 Inhibitor I is a chemical compound used predominantly in biochemical research, particularly in the study of apoptosis. It is a synthetic, reversible inhibitor derived from known peptide inhibitors of caspase enzymes. The inhibitor functions by blocking the active sites of caspase-3 and caspase-7 enzymes, halting their protease activity, which is crucial in the execution phase of apoptosis.</p>

<p>Nutlin carboxylic acid is a small molecule inhibitor, which is derived from synthetic sources targeting the p53-MDM2 interaction with high specificity and efficacy. It functions by binding to the MDM2 protein, effectively preventing it from interacting with the tumor suppressor protein p53. This inhibition stabilizes and activates p53, leading to cell cycle arrest and apoptosis in cancerous cells.</p>

<p>MBX2546 is a synthetic biochemical compound, which is derived from advanced chemical synthesis techniques to create a stable and reactive molecular structure. Its design leverages cutting-edge methodologies in organic chemistry, allowing for precise customization at the atomic level. With a mode of action that involves binding to specific molecular targets, MBX2546 can modulate or inhibit biochemical pathways of interest, providing a powerful tool for investigators aiming to dissect complex biological processes.</p>

<p>A 331440 Dihydrochloride is a potent and selective NMDA receptor antagonist, which is a synthetic compound with notable binding affinity for modulating excitatory synaptic transmission. This product is derived from chemical synthesis, designed specifically for research applications involving neuronal signaling pathways. Its mode of action involves blocking the ion channels associated with NMDA receptors, thereby inhibiting the flow of calcium ions across the cell membrane.</p>

<p>Agomelatine (L(+)-tartaric acid) is a synthetic antidepressant, which is derived from chemical synthesis. It acts primarily by serving as an agonist at melatonin MT1 and MT2 receptors and as an antagonist at 5-HT2C serotonin receptors. This dual mechanism of action is particularly significant as it helps regulate sleep-wake cycles and mood by re-establishing normal circadian rhythms.</p>

<p>RWJ 52353 is a synthetic small molecule, which is an investigational drug developed through medicinal chemistry techniques aimed at targeting metabolic pathways. With a specific mode of action that involves inhibiting key enzymes involved in metabolic processes, it modulates biological pathways associated with energy homeostasis.</p>

<p>3-[1,1′-Biphenyl]-2-yl-5-(1-methyl-1H-pyrazol-4-yl)furo[3,2-b]pyridine is a chemical compound designed for use in scientific research, particularly within the field of biochemistry and pharmacology. This compound is typically synthesized through organic chemical processes involving biphenyl and furo[3,2-b]pyridine derivatives. It is known for its specific binding affinity and interaction with certain biological targets, which makes it significant in the investigation of cellular pathways and receptor activities.</p>

<p>AC 186 is a synthetic small-molecule inhibitor, which is derived from targeted chemical synthesis with specificity for protein modulation. The compound acts by competitively binding to the active site of the target protein, disrupting its interaction with other biomolecules, and thereby inhibiting its biological activity. This mechanism of action allows for the selective modulation of signaling pathways and cellular processes, making AC 186 a valuable tool for in-depth biochemical studies.</p>

<p>Ro 67-7476 is a synthetic compound that functions as a potent, non-peptide antagonist for the cholecystokinin-A (CCK-A) receptor. The source of this compound is chemical synthesis, utilizing advanced organic chemistry techniques to specifically target the CCK-A receptor with high affinity and selectivity. The mode of action involves the competitive inhibition of the natural ligand binding to the CCK-A receptor, thereby modulating the physiological responses mediated through this receptor pathway.</p>

<p>Please enquire for more information about Diabzi sting agonist-1 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>HMN-176 is a synthetic antifungal compound, which is an indolocarbazole derivative sourced from a natural alkaloid framework. This product exhibits its mode of action by inhibiting fungal cell division, specifically through interference with microtubule polymerization. This mechanism effectively disrupts the mitotic process, leading to cell cycle arrest and subsequent fungal cell death.</p>

<p>Isavuconazole-d4 is a deuterated antifungal agent specifically designed as an isotopically labeled analog of Isavuconazole, a triazole antifungal. This product is sourced from the chemical modification of Isavuconazole, where deuterium atoms replace certain hydrogen atoms. The introduction of deuterium enhances the mass for analytical precision without altering pharmacological activity, making it ideal for rigorous scientific studies.</p>

<p>Please enquire for more information about MDL-29951 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>JTV-519 hemifumarate is a calcium sensitizer, which is a pharmaceutical agent designed to improve cardiac contractility. It is derived from a synthetic process focusing on modulating calcium dynamics within cardiac cells. By binding to and stabilizing the ryanodine receptor (RyR2), JTV-519 hemifumarate enhances calcium release from the sarcoplasmic reticulum during the cardiac cycle. This action leads to an increase in the sensitivity of cardiac myofilaments to calcium without increasing intracellular calcium concentration, thereby improving myocardial contractility without the pro-arrhythmic effects associated with increased calcium transients.</p>

<p>Please enquire for more information about AZ876 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>CY-09 is a fluorescent probe-based cell assay system, which is a synthetic compound designed for biomedical research. The product is developed from a combination of advanced chemical synthesis methods and molecular engineering, allowing precise interactions with cellular processes. CY-09 operates via a fluorescence-based detection mechanism, providing a highly specific and sensitive means to observe intracellular events.</p>

<p>Pyrisoxazole is a synthetic fungicide, which is a man-made chemical compound used to inhibit fungal growth. It functions by targeting and disrupting the synthesis of essential components of the fungal cell membrane, specifically inhibiting ergosterol biosynthesis, which is crucial for maintaining cell integrity and function. Pyrisoxazole is utilized primarily in agricultural settings to protect crops from various fungal pathogens. By preventing the invasion and spread of fungi, it helps in maintaining crop yield and quality. Its efficacy against a wide range of fungi makes it a valuable tool in integrated pest management strategies, ensuring sustainable agricultural practices. The ability to selectively target fungal cells while sparing plant and animal cells is a notable characteristic, underscoring its specificity and utility in crop protection.</p>

<p>18:1 (N12) Coenzyme A is a lipid molecule, which is a derivative of oleic acid conjugated to coenzyme A. It is synthesized from natural sources through enzymatic processes involving oleic acid, a monounsaturated fatty acid, and coenzyme A, a crucial cofactor in various biochemical pathways. The mechanism of action for 18:1 (N12) Coenzyme A involves its participation as an acyl carrier in the enzymatic synthesis and oxidation of fatty acids. As a result, it plays an essential role in fatty acid metabolism, influencing lipid biosynthesis and energy production.</p>

<p>Dasotraline is a dopamine and norepinephrine reuptake inhibitor (DNRI), which is a small-molecule pharmaceutical developed for potential therapeutic use. This compound originates from synthetic chemical processes designed to modulate neurotransmitter activity within the central nervous system. The mode of action of dasotraline involves the inhibition of dopamine and norepinephrine transporters. By blocking the reuptake of these neurotransmitters, dasotraline increases their extracellular concentrations, thereby enhancing dopaminergic and noradrenergic signaling.</p>

<p>Deshydroxyethoxy Ticagrelor is a metabolite that emerges as a derivative of the antiplatelet medication Ticagrelor. This compound originates from the biotransformation processes in the human body, where Ticagrelor undergoes metabolic conversion. As a metabolite, Deshydroxyethoxy Ticagrelor retains activity, contributing to the parent compound's overall therapeutic effect. The primary mode of action involves the reversible inhibition of the P2Y12 receptor on platelets, which plays a crucial role in the inhibition of platelet aggregation.<br><br>The applications of Deshydroxyethoxy Ticagrelor are primarily linked to the study of its pharmacokinetic and pharmacodynamic properties to understand better its contribution to Ticagrelor's efficacy and safety profile. Such insights can help refine dosing strategies and therapeutic regimens in clinical settings, enhancing antiplatelet therapy's precision, especially in managing acute coronary syndromes and preventing thrombotic vascular events. Understanding this metabolite is essential for developing next-generation antiplatelet agents and optimizing current treatment protocols.</p>

<p>18:0 Lyso PI is a lysophosphatidylinositol, which is a lipid molecule, specifically a type of phosphoinositide. It is derived from natural sources of phospholipids, often found within cell membranes. The mode of action involves participating in cellular signaling pathways, acting as a precursor or mediator in the phosphoinositide cycle. This cycle is crucial for regulating various cellular processes, including signal transduction, cell differentiation, and membrane trafficking.</p>

<p>2'-((2-(4-Methoxyphenyl)acetamido)methyl)-N-(2-(pyridin-3-yl)ethyl)-[1,1'-biphenyl]-2-carboxamide is a synthetic compound characterized by its biphenyl carboxamide structure. It is derived through organic synthesis involving the strategic assembly of methoxyphenyl, pyridine, and carboxamide moieties.</p>

<p>Tert-Butyl 4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperidine-1-carboxylate is a synthetic organic compound typically used in the field of chemical research. It belongs to the class of oxadiazole derivatives, which are known for their diverse chemical and pharmacological properties. The source of this compound is through systematic organic synthesis methods, involving multi-step reactions that strategically build the complex molecular structure.</p>

<p>Cilengitide trifluoroacetate is a cyclic pentapeptide, which is a synthetic compound originally derived from natural peptides. Its source lies in the laboratory synthesis of cyclic RGD (Arg-Gly-Asp) peptides, which are known for their ability to interact with specific integrins on cell surfaces. Cilengitide selectively targets integrin αvβ3 and αvβ5, modulating cell adhesion and signaling pathways that are crucial in tumor angiogenesis, cancer growth, and metastasis.</p>

<p>Psi-7977-13C-d3 is a stable isotope-labeled compound, a modified version of sofosbuvir, which is a well-known nucleotide analog. It is synthesized to incorporate carbon-13 and deuterium, making it useful for pharmacokinetic studies. The isotopic labeling allows researchers to trace the metabolic pathways and disposition of the drug in biological systems with high precision.</p>

<p>an ADC drug-linker conjugate composed of an DX-8951 derivative (Exatecan) and a maleimide-GGFG peptide linker.</p>

<p>Please enquire for more information about Auglurant including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Biricodar dicitrate (vx-710 dicitrate) is a chemosensitizing agent, which is a synthetic compound designed to modulate drug resistance mechanisms. It is sourced from research efforts aimed at overcoming multidrug resistance in cancer. Biricodar dicitrate acts by inhibiting members of the ATP-binding cassette (ABC) transporter family, particularly P-glycoprotein (P-gp) and multidrug resistance-associated proteins (MRPs). These transporters typically efflux chemotherapeutic agents out of cancer cells, thereby reducing drug accumulation and efficacy.</p>

<p>1-Deoxysphinganine-d3 is an isotopically labeled sphingolipid analog, which is a synthetic derivative of naturally occurring sphingoid bases. It is derived through a process of selective deuterium labeling, replacing hydrogen atoms with deuterium at three specific positions. This modification allows for its use in precise mass spectrometric studies due to the distinct mass difference imparted by deuterium. Its mode of action involves mimicking sphingolipid metabolic pathways, enabling the investigation of sphingolipid-associated functions in cells without influencing the biological activity as a substrate in enzymatic reactions.</p>

<p>TCS 2510 is a chemical compound, specifically a selective inhibitor, derived from synthetic organic chemistry. This compound exhibits its functional mechanism through targeted interaction with specific enzymes or proteins, thereby modulating their biological activity. The mode of action typically involves binding to the active site or allosteric site, resulting in altered enzyme activity, which can aid in elucidating pathways and biological processes.</p>

<p>MM 11253 is a sophisticated biotechnological research reagent, which is derived from a combination of recombinant DNA technology and protein engineering techniques. Its mode of action involves specific binding to nucleic acid sequences, thus enabling precise manipulation and analysis of genetic material. By leveraging its specific binding properties, MM 11253 can be used to facilitate various genetic studies, including gene expression analysis, DNA sequencing, and genomic mapping.</p>

<p>FR 171113 is a synthetic chemical compound classified as a novel antimicrobial agent, which is derived from intricate laboratory synthesis processes. The compound acts primarily by disrupting bacterial cell wall synthesis, interfering with essential processes that sustain the bacterial cell structure, leading to eventual cell lysis.</p>

<p>Brm/BRG1 ATP Inhibitor-1 is a small-molecule inhibitor specifically developed to target the ATPase activity of the Brm and BRG1 proteins, which are core components of the SWI/SNF chromatin remodeling complexes. These complexes are vital for modulating chromatin structure to regulate gene expression in eukaryotic cells. The source of the Brm/BRG1 ATP Inhibitor-1 is synthetic chemical synthesis, designed to interfere with the ATP-dependent activity of the SWI/SNF complex.</p>

<p>PS-1145 dihydrochloride is a synthetic chemical compound that acts as a selective inhibitor of the enzyme IκB kinase β (IKK-β). This compound is typically derived through complex chemical synthesis techniques in laboratory environments. PS-1145 targets the NF-κB signaling pathway by directly binding to IKK-β, thereby inhibiting its activity. This inhibition prevents the phosphorylation and subsequent degradation of IκB proteins, which in turn retains NF-κB in the cytoplasm and prevents its transcriptional activity in the nucleus.</p>

<p>JNJ-632 is an investigational therapeutic agent, specifically a small molecule degrader, which is derived from synthetic chemical processes. The product is designed to selectively induce the degradation of specific proteins associated with cancer proliferation. This is achieved through a targeted protein degradation mechanism, wherein JNJ-632 binds to the target protein and recruits an E3 ubiquitin ligase, leading to ubiquitination and subsequent proteasomal degradation of the target protein.</p>

<p>JNJ-40418677 is a small-molecule pharmaceutical compound that functions as a highly selective phosphodiesterase 10A (PDE10A) inhibitor. It is developed from synthetic chemical sources and is designed to modulate intracellular signaling pathways by targeting the PDE10A enzyme. The mode of action involves inhibition of PDE10A, which is predominantly expressed in the striatum—a brain region linked to motor control and cognitive functions. By inhibiting PDE10A, JNJ-40418677 increases the levels of cyclic nucleotides (cAMP and cGMP) within neurons, which can enhance dopaminergic and glutamatergic signaling pathways.</p>

<p>VTX-27 is an innovative bioengineered compound, which is synthesized through a combination of cutting-edge biotechnological and synthetic chemistry techniques. This product acts by modulating specific biological pathways, leveraging its unique molecular structure to interact with targeted receptors or enzymes, thereby altering cellular functions in a highly controlled manner. VTX-27 is primarily used for its potential in therapeutic applications, particularly in the fields of oncology and neurodegenerative disorders. The precise modulation of pathways allows for investigation into novel treatments, offering insights into disease mechanisms and potentially leading to the development of more effective therapeutic strategies with minimized side effects. Scientists are exploring VTX-27 to understand its efficacy and safety profiles, aiming to contribute to the next generation of targeted treatment options.</p>

<p>PD-1-IN-1 is an inhibitor targeting the programmed cell death protein 1 (PD-1), a key immune checkpoint receptor. This product is chemically synthesized, ensuring a high degree of purity and specific activity. The mode of action involves the blockade of the PD-1 pathway, thereby inhibiting the interaction between PD-1 on T cells and its ligands, PD-L1 and PD-L2, on other cells. This interruption enhances T cell activity and prevents immune evasion by tumors or infected cells, making it a vital tool in immuno-oncology research.</p>

<p>Atagabalin is a novel pharmaceutical compound, which is derived from marine biological sources. Its primary mode of action involves the inhibition of the alpha-2-delta subunit of voltage-gated calcium channels. This mechanism modulates synaptic transmission, leading to reduced neuronal excitability.</p>

<p>AG 1406 is a small molecule that modulates the expression of genes that are involved in nerve function. The protein-protein interactions of AG 1406 were examined using a microarray and cytoscape. This agent was found to interact with nuclear factor-kappa B, which is an inflammatory pathway that is activated by cytokines and stress. AG 1406 also interacts with metal surfaces, such as those present on glyphosate, to produce an inhibitory effect on the growth of plants.</p>

<p>Curcumin-d6 is a stable isotopic labeled compound, which is derived from the natural polyphenolic compound curcumin sourced from the plant Curcuma longa. As a deuterated analogue, its structure contains six deuterium atoms, which aid in various analytical applications. The mode of action for Curcumin-d6 involves providing a reference standard for mass spectrometry and nuclear magnetic resonance (NMR) studies, where its isotopic composition allows for precise, quantitative analysis and differentiation from non-labeled compounds.</p>

<p>Stylopine hydrochloride is an isoquinoline alkaloid, which is a naturally occurring compound primarily extracted from plants in the Papaveraceae family, such as Papaver and Corydalis species. Its mode of action involves the inhibition of certain enzymes and modulation of calcium channels, which are critical in the regulation of various biochemical pathways.</p>

<p>CYM 50308 is a synthetic herbicide, which is synthesized through chemical processes designed to target specific plant physiological pathways. Its mode of action involves the inhibition of key enzyme pathways that are essential for the biosynthesis of amino acids in plants. This disruption leads to the cessation of protein synthesis, ultimately causing the death of targeted weed species.</p>

<p>06:0-06:0 NBD pg is a synthetic fluorescence probe which is used in the field of biochemistry and cell biology. This product is derived from phosphatidylglycerol and carries a nitrobenzoxadiazole (NBD) fluorescent group attached through an acyl chain. The mode of action involves the incorporation of the NBD-labeled lipid into biological membranes or liposomes, enabling visualization and analysis of lipid behavior and protein-membrane interactions under a fluorescence microscope or via spectroscopic methods.</p>

<p>SIS3 is a selective inhibitor of Signal Transducer and Activator of Transcription 3 (STAT3), which is a key transcription factor often implicated in cancer and other diseases. This chemical compound is synthetically derived, allowing for precise targeting of STAT3 without affecting structurally similar molecules, thereby providing a more refined approach to inhibition.</p>

<p>Jaspamycin is an antitumor antibiotic, which is a natural product isolated from the bacterium *Streptomyces hygroscopicus*. Its mode of action involves disrupting RNA synthesis by inhibiting nucleic acid chain elongation, thereby impeding cell proliferation and leading to cell death in rapidly dividing cancer cells. This mechanism makes Jaspamycin particularly effective as a chemotherapeutic agent.</p>

<p>Please enquire for more information about SDZ 220-581 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>GSK2850163 is a small-molecule inhibitor, which is derived synthetically. It functions by selectively targeting bromodomains, which are protein interaction modules that recognize acetylated lysine residues. This action disrupts the interaction between bromodomains and acetylated histones, thereby influencing gene expression. Such selective targeting allows for modulation of transcriptional programs that can be aberrant in various diseases.</p>

<p>MS436 is a synthetic small molecule inhibitor, which is designed through rational drug design and chemical synthesis. It functions by specifically inhibiting bromodomain-containing proteins, particularly targeting the BET (bromodomain and extra-terminal) family proteins. The mode of action involves binding to the acetyl-lysine recognition domains, thereby preventing the interaction of these proteins with acetylated histones, which disrupts transcriptional regulation.<br><br>MS436 is primarily used in biomedical research to study epigenetic regulation and its effects on gene expression. Its applications are pivotal in exploring the mechanisms underlying various diseases, including cancers, where dysregulation of BET proteins is often implicated. Researchers utilize MS436 to elucidate pathways involved in cell cycle regulation, apoptosis, and differentiation. By modulating these pathways, MS436 aids in advancing our understanding of disease pathogenesis, facilitating the development of therapeutic strategies. As such, its use is crucial in preclinical studies that aim to validate the potential therapeutic targets within the epigenetic landscape.</p>

<p>Tyrosine kinase inhibitor; affects EGFR receptor; pancreatic cancer treatment</p>

<p>SW155246 is a synthetic chemical compound, classified as a small-molecule inhibitor, which is derived from advanced organic synthesis techniques. Its mode of action involves the selective inhibition of specific enzymatic pathways, thereby modulating the activity of targeted proteins within cellular environments. This precision allows researchers to dissect and understand intricate biochemical processes.</p>

<p>CM-675 is a specialized chemical compound designed for laboratory and industrial research, which originates from advanced chemical synthesis techniques. This compound functions by offering distinct reaction pathways or interactions at a molecular level, crucial for facilitating complex chemical reactions or processes.</p>

<p>Akt-I-1,2 HCl is a selective Akt inhibitor, which is a synthetic chemical compound designed to target and modulate kinase activity. It originates from pharmaceutical research focused on developing therapies for diseases driven by dysregulated Akt signaling pathways. The mode of action of Akt-I-1,2 HCl involves the inhibition of Akt serine/threonine kinases, interfering with phosphorylation events that are crucial for Akt-mediated signaling. This blockade results in the modulation of cellular processes such as growth, survival, and metabolism, which are often aberrant in cancer cells.</p>

<p>(R)-DPN is a selective agonist, which is a chemical compound primarily sourced through synthetic organic chemistry techniques. Its mode of action involves specifically binding to and activating the estrogen-related receptor gamma (ERRγ), a member of the nuclear receptor superfamily. By acting as a highly selective ligand, (R)-DPN modulates the transcriptional activity associated with the ERRγ receptor, influencing various biological pathways.</p>

<p>ML 18 is a novel antibiotic compound, which is a product derived from a newly identified bacterium species known as Streptomyces. This source bacterium has been isolated from unique soil environments that promote the synthesis of distinct secondary metabolites. ML 18 functions by inhibiting bacterial protein synthesis, specifically targeting the ribosomal subunits, leading to the cessation of bacterial growth and eventual cell death.</p>

<p>Procinolol is a pharmaceutical compound classified as a beta-adrenergic blocker, which is a type of medication derived from synthetic sources. Its primary mode of action involves the competitive antagonism of beta-adrenergic receptors, particularly in cardiac tissue, leading to a decrease in heart rate and myocardial contractility. This mechanism results in a reduction of cardiac output, which consequently lowers blood pressure and myocardial oxygen demand.</p>

<p>LY 2922470 is an investigational compound, which is a small molecule inhibitor, derived from synthetic chemical sources, with specific activity against certain kinase enzymes. The mode of action of LY 2922470 involves binding to the ATP pocket of the targeted kinases, thereby inhibiting their phosphorylation activity, which is crucial in signaling pathways that regulate cell proliferation and survival.</p>

<p>Vonoprazan fumarate is a pharmaceutical compound that functions as a potassium-competitive acid blocker (PCAB), which is derived from synthetic sources. It acts by selectively inhibiting the gastric hydrogen-potassium ATPase enzyme, commonly known as the proton pump, located in the stomach lining. This mode of action results in a significant reduction in gastric acid secretion, offering a therapeutic alternative to traditional proton pump inhibitors (PPIs).</p>

<p>Please enquire for more information about ACT 335827 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>S3QEL 2 is a compound that targets selective suppression of superoxide, a reactive oxygen species, exclusively from the mitochondrial respiratory complex I. It is categorized as a small-molecule inhibitor developed from biochemical research focused on mitochondrial function regulation. S3QEL 2 acts by specifically interacting with a site on the complex I that is responsible for superoxide production, thereby reducing oxidative stress within cells without interfering with the other normal functions of the electron transport chain.</p>

<p>MMSET-IN-1 is a small molecule inhibitor specifically designed to target the histone methyltransferase activity of MMSET (also known as NSD2 or WHSC1). This compound originates from a synthetic chemical library explicitly developed for epigenetic research. The mode of action involves the selective inhibition of MMSET's enzymatic function, which is responsible for di- and tri-methylation of lysine 36 on histone H3 (H3K36me2/3).</p>

<p>Ethyl rosmarinate is an esterified derivative of rosmarinic acid, which is naturally sourced from the rosemary plant (Rosmarinus officinalis). This compound exhibits potent antioxidant properties, acting primarily by scavenging free radicals and inhibiting lipid peroxidation. These mechanisms allow it to mitigate oxidative stress within biological systems.</p>

<p>GLPG 0974 is an experimental pharmaceutical compound, specifically an antagonist of the free fatty acid receptor 2 (FFA2), also known as GPR43. This compound is synthesized through a process of chemical engineering aimed at selectively inhibiting GPR43's activity. The mode of action involves blocking the interaction of short-chain fatty acids with GPR43, a receptor implicated in inflammatory pathways.</p>

<p>TMPH Hydrochloride is a synthetic chemical compound commonly utilized in biochemical research. It is derived from synthetic processes involving organic chemistry techniques. The mode of action of TMPH Hydrochloride involves its interaction with neurotransmitter systems, where it functions by modulating receptor activity or inhibiting specific enzymatic pathways.</p>

<p>Gambogenic acid is a naturally occurring compound, which is a diterpenoid extracted from the resin of the Garcinia hanburyi tree. The source of this product is primarily in Southeast Asia, where the plant species is native. Gambogenic acid acts by modulating intracellular signaling pathways, leading to the induction of apoptosis and the inhibition of proliferation in cancer cells. It primarily targets pathways such as the NF-κB and PI3K/Akt, which are crucial for cell survival and growth, thereby exhibiting its antiproliferative effects.</p>

<p>(2R,3S)-E1R is a chiral chemical compound used in advanced research and pharmaceutical development. It is synthesized through a series of stereochemical reactions to ensure precise enantiomeric purity. The compound is typically derived from complex organic synthesis involving enantioselective catalysts, ensuring that its specific 2R,3S configuration is maintained.</p>

<p>SSE15206 is a chemical compound commonly referred to as an intermediate in organic synthesis. It is derived from complex chemical precursors through an extensive series of reactions involving catalysts and controlled conditions. This compound serves a pivotal role in the synthetic pathway by enabling the construction of more intricate molecules.</p>

<p>Palbociclib dihydrochloride is a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), which is derived from synthetic chemical processes. Its mode of action involves disrupting the progression of the cell cycle from G1 to S phase, thereby inhibiting cellular proliferation. By specifically targeting and inhibiting CDK4/6, Palbociclib effectively arrests the growth of cancer cells that rely on these kinases for division.</p>

<p>QZ59S-SSS is an innovative biochemical reagent, which is derived from a synthetic molecular framework designed for specificity in biochemical interactions. This product operates through selective molecular binding, enabling targeted engagement with specific cellular or molecular entities. It employs precision in its mode of action, ensuring minimal non-specific interactions, which is critical for experimental accuracy in various research settings.</p>

<p>4-(2-(1H-Imidazol-1-yl)ethoxy)benzoic acid hydrochloride is a synthetic chemical compound, which is typically sourced through organic synthesis methods. This compound is characterized by its unique structure featuring an imidazole group linked to a benzoic acid moiety via an ethoxy bridge. The mode of action of this compound predominantly involves interactions at a molecular level with various biological targets, potentially influencing biochemical pathways by mimicking or inhibiting natural biological molecules.</p>

<p>E6446 (dihydrochloride) is a small molecule compound that acts as a selective inhibitor of the mitotic kinesin Eg5, also known as KIF11. This compound is synthetically derived and is typically utilized in laboratory research. Its mode of action involves binding to the motor domain of Eg5, thereby inhibiting its ATPase activity, which is crucial for the Eg5-driven separation of spindle poles during cell mitosis. By selectively targeting Eg5, E6446 effectively disrupts mitotic spindle formation, leading to cell cycle arrest and apoptosis in rapidly dividing cells.<br><br>These characteristics make E6446 an important tool in scientific research, particularly in the study of cancer cells and the development of anticancer therapies. Its ability to halt cell division without affecting other kinesins provides researchers with a precise method to investigate the role of mitotic kinesins in cell cycle progression and to screen for potential therapeutic compounds.</p>

<p>Sitoindoside I is a naturally occurring glycoside, which is isolated from the plant Withania somnifera, commonly known as Ashwagandha. It functions as a bioactive compound with adaptogenic properties, which means it helps the body resist the physiological impacts of stress. The chemical structure of Sitoindoside I contributes to its ability to modulate various neurochemical pathways, which is critical in the regulation of stress responses.</p>

<p>Sonepiprazole hydrochloride is an experimental pharmaceutical compound, which is derived from synthetic sources with a high degree of chemical precision. This compound acts as a selective dopamine D4 receptor antagonist, modulating neurochemical transmission by inhibiting D4 receptor activity. The specificity for the D4 receptor suggests its potential use in elucidating the pathophysiology of conditions such as schizophrenia and other neuropsychiatric disorders. Research into Sonepiprazole hydrochloride focuses on its efficacy in altering dopaminergic pathways, which may contribute to improved cognitive and behavioral functions in preclinical models. While its exact therapeutic potential remains under study, Sonepiprazole hydrochloride represents a promising avenue in the development of targeted treatments for psychiatric conditions where dopamine dysregulation is implicated.</p>

<p>HJC0152 Hydrochloride is a research compound that acts as a selective agonist of the sphingosine-1-phosphate receptor 5 (S1P5). This compound originates from synthetic chemical sources, where it is meticulously crafted to interact specifically with the S1P5 receptor. Through binding to this receptor, HJC0152 Hydrochloride modulates signaling pathways involved in cellular processes, particularly within the central nervous system.</p>

<p>WEHI-539 hydrochloride is a chemical compound that functions as a potent and selective Bcl-XL inhibitor. It is synthetically derived and serves as a valuable tool in the study of apoptotic pathways. Bcl-XL is a member of the Bcl-2 family of proteins, which are critical regulators of apoptosis, and its inhibition can promote cell death in cancer cells that rely on this pathway for survival.</p>

<p>12:0 Lyso NBD PC is a fluorescent lipid probe, which is an analog of lysophosphatidylcholine. This synthetic product is derived from phospholipids modified with a NBD (7-nitro-2-1,3-benzoxadiazol-4-yl) fluorophore. Its primary manner of action involves integration into cellular membranes, where it enhances the visualization of lipid domains and membrane trafficking through fluorescence microscopy or flow cytometry.</p>

<p>Ciwujianoside A1 is a saponin compound, which is isolated from the roots of the Eleutherococcus senticosus plant, commonly known as Siberian ginseng. This compound belongs to the family of triterpenoid saponins, which are notable for their diverse biological activities. Ciwujianoside A1 primarily acts by interacting with specific cellular pathways, including modulating immune responses and exerting antioxidative effects.</p>

<p>XL888 is a selective and potent inhibitor of heat shock protein 90 (HSP90), which is a molecular chaperone involved in the proper folding, stability, and function of many client proteins, including those critical in cancer progression. Sourced from rigorous medicinal chemistry processes, XL888 is designed to bind to the ATP-binding site of HSP90, thereby inhibiting its chaperone activity. This inhibition leads to the degradation of client proteins that are essential for tumor growth and survival.</p>

<p>Inhibitor of vacuolar ATP-ases</p>

<p>Pd-85639 is a synthetic small molecule, which is a product of laboratory-derived chemical synthesis. Its structure mimics certain naturally occurring biomolecules that interact with cellular pathways pivotal in the regulation of cell growth and apoptosis. Specifically, Pd-85639 operates by inhibiting specific enzymes and signaling pathways, leading to the disruption of malignant cell proliferation and induction of programmed cell death.</p>

<p>KDM4D-IN-1 is a chemical compound that acts as a selective inhibitor. It is derived synthetically to target the KDM4D enzyme, a member of the Jumonji family of histone demethylases. The mode of action involves the inhibition of the catalytic activity of KDM4D, which regulates the demethylation of lysine residues on histones, specifically demethylating H3K9me3/me2. This regulation plays a significant role in chromatin remodeling and gene expression.</p>

<p>MAY0132 is an innovative biopolymer that is derived through advanced fungal fermentation processes. This product is developed utilizing cutting-edge biotechnology techniques, where specific fungal strains are cultivated and optimized to produce high-molecular-weight polymers. The mode of action involves the biosynthesis of these polymers through the metabolic pathways of the fungi, resulting in a sustainable and environmentally friendly material.</p>

<p>(4-Chloro-6-((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methoxy)-1-benzothiophen-3-yl)acetic acid is a highly specialized agrochemical compound, which is synthesized through complex organic reactions. It acts primarily as a herbicide, disrupting plant physiological processes by inhibiting specific enzymes necessary for growth, particularly in broadleaf weeds.</p>